On ECHEMI
Home > Drugs > Hubei Wushi Pharmaceutical Co., Ltd.
Hubei Wushi Pharmaceutical Co., Ltd.
  • Founded in:

    1997-11-19
  • Country:

    China China
  • Address:

    No. 137, Biyu Road, Anlu City, Hubei Province
  • Tax NO.:

    91420000180960817C
  • Registered Funds:

    100 million yuan
  • Website:

  • Email:

Related Drugs
Golden Rosa Lagenaria Cream
Rosa rugosa.
Name Description Content CAS NO. Registered Holders
Rosae Laevigatae Fructus

1. It has the effect of reducing urination. Rosa laevigata can reduce the number of urinations, prolong the interval between urinations, and increase the amount of urine per urination in the rat model of frequent urination caused by cutting the hypogastric nerve. 2. It has the effect of inhibiting smooth muscle contraction. Rosa laevigata can antagonize the spasmodic contraction of isolated bladder smooth muscle of rats and jejunal smooth muscle of rabbits induced by acetylcholine and barium chloride, inhibit the autonomous contraction of isolated jejunal smooth muscle of rabbits, and antagonize the contraction reaction of rabbit thoracic aorta strips induced by norepinephrine.

More

1. It has the effect of reducing urination. Rosa laevigata can reduce the number of urinations, prolong the interval between urinations, and increase the amount of urine per urination in the rat model of frequent urination caused by cutting the hypogastric nerve. 2. It has the effect of inhibiting smooth muscle contraction. Rosa laevigata can antagonize the spasmodic contraction of isolated bladder smooth muscle of rats and jejunal smooth muscle of rabbits induced by acetylcholine and barium chloride, inhibit the autonomous contraction of isolated jejunal smooth muscle of rabbits, and antagonize the contraction reaction of rabbit thoracic aorta strips induced by norepinephrine.

0
Yinhua Cold Granules
Honeysuckle, forsythia, siler, platycodon, liquorice. Auxiliary materials: sucrose, starch.
Name Description Content CAS NO. Registered Holders
LONICERAE JAPONICAE FLOS

0
Forsythiae Fructus

0
SAPOSHNIKOVIAE RADIX

0
Platycodonis Radix

0
DGL

0
Sucrose

57-50-1 72
Starch

9005-25-8 78
Levofloxacin Mesylate for Injection
The main ingredients of this product are: Levofloxacin mesylate
Name Description Content CAS NO. Registered Holders
Levofloxacin mesylate

It achieves antibacterial effect by inhibiting the activity of bacterial DNA gyrase (bacterial topoisomerase II) and hindering the replication of bacterial DNA. It has good antibacterial effect on most Enterobacteriaceae, Gram-negative bacteria, some Gram-positive bacteria, Legionella, Mycoplasma, Chlamydia, but has poor effect on anaerobic bacteria and enterococci.

More

It achieves antibacterial effect by inhibiting the activity of bacterial DNA gyrase (bacterial topoisomerase II) and hindering the replication of bacterial DNA. It has good antibacterial effect on most Enterobacteriaceae, Gram-negative bacteria, some Gram-positive bacteria, Legionella, Mycoplasma, Chlamydia, but has poor effect on anaerobic bacteria and enterococci.

226578-51-4 23
Levofloxacin Mesylate for Injection
The main ingredients of this product are: Levofloxacin mesylate
Name Description Content CAS NO. Registered Holders
Levofloxacin mesylate

It achieves antibacterial effect by inhibiting the activity of bacterial DNA gyrase and hindering the replication of bacterial DNA. It has the characteristics of broad antibacterial spectrum and strong antibacterial effect, and has good antibacterial effect on most Enterobacteriaceae, Gram-negative bacteria, some Gram-positive bacteria, Legionella, Mycoplasma, Chlamydia, but has poor effect on anaerobic bacteria and enterococci.

More

It achieves antibacterial effect by inhibiting the activity of bacterial DNA gyrase and hindering the replication of bacterial DNA. It has the characteristics of broad antibacterial spectrum and strong antibacterial effect, and has good antibacterial effect on most Enterobacteriaceae, Gram-negative bacteria, some Gram-positive bacteria, Legionella, Mycoplasma, Chlamydia, but has poor effect on anaerobic bacteria and enterococci.

226578-51-4 23
Levofloxacin mesylate
Levofloxacin mesylate.
Name Description Content CAS NO. Registered Holders
Levofloxacin mesylate

This product has a broad-spectrum antibacterial effect and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae, such as Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, and Gram-negative bacteria such as Haemophilus influenzae, Legionella pneumophila, and Neisseria gonorrhoeae. It also has antibacterial effects on Gram-positive bacteria such as Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, and Mycoplasma pneumoniae and Chlamydia pneumoniae, but has poor effects on anaerobic bacteria and enterococci. Its mechanism of action is to inhibit the activity of bacterial DNA gyrase, prevent the synthesis and replication of bacterial DNA, and cause bacterial death.

More

This product has a broad-spectrum antibacterial effect and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae, such as Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, and Gram-negative bacteria such as Haemophilus influenzae, Legionella pneumophila, and Neisseria gonorrhoeae. It also has antibacterial effects on Gram-positive bacteria such as Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, and Mycoplasma pneumoniae and Chlamydia pneumoniae, but has poor effects on anaerobic bacteria and enterococci. Its mechanism of action is to inhibit the activity of bacterial DNA gyrase, prevent the synthesis and replication of bacterial DNA, and cause bacterial death.

226578-51-4 23
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.